Previous 10 | Next 10 |
BTIG is out with its Highest Conviction Ideas for the next 12 months... Some of its top ideas follow, starting with consumer stocks: More news on: Chipotle Mexican Grill, Inc., Papa John's International, Inc., D.R. Horton, Inc., Notable Calls, Read more ...
SOUTH SAN FRANCISCO, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the establishment of a new Center of Excellence (CoE) for Imagin...
SOUTH SAN FRANCISCO, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the introduction of the AccuLift™ Laser Capture Mi...
Acquisition to expand Fluidigm’s industry-leading mass cytometry capabilities and address flow cytometry markets with the addition of fully automated sample prep SOUTH SAN FRANCISCO, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biot...
Fluidigm Corporation (FLDM) Q4 2019 Results Earnings Conference Call February 10, 2020, 05:00 PM ET Company Participants Agnes Lee - VP, IR Chris Linthwaite - President and CEO Vikram Jog - CFO Conference Call Participants Sung Ji Nam - BTIG Bill Quirk - Piper Sandler A...
The following slide deck was published by Fluidigm Corporation in conjunction with their 2019 Q4 earnings Read more ...
Gainers: AMKR +14.5% . FLDM +14.1% . LPTX +7.5% . XPO +3.6% . OMF +3.4% . More news on: Amkor Technology, Inc., Fluidigm Corporation, Leap Therapeutics, Inc., Stocks on the move, , , News on ETFs Read more ...
Fluidigm (NASDAQ: FLDM ): Q4 Non-GAAP EPS of -$0.03 beats by $0.06 ; GAAP EPS of -$0.18 beats by $0.01 . Revenue of $32.44M (+0.3% Y/Y) beats by $0.3M . Press Release More news on: Fluidigm Corporation, Earnings news and commentary, Tech stocks news,
Fourth quarter revenue of $32.4 million Full year 2019 revenue increased 4 percent to $117.2 million; full year mass cytometry revenue increased 23 percent Landmark Nature publication demonstrates potential clinical value of using Imaging Mass Cytometry Covance selects ...
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will establish a new Center of Excellence (CoE) for Imag...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report second quarter 2024 financial results on Wednesday, July 31, 2024, after the close of the...
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSA XT system from Carterra ® , a leading provider of high-throughput large and small molecule screening and characteriza...
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025 Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of app...